BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Williams I. Epidemiology of hepatitis C in the United States. Am J Med. 1999;107:2S-9S. [PMID: 10653448 DOI: 10.1016/s0002-9343(99)00373-3] [Cited by in Crossref: 156] [Cited by in F6Publishing: 52] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 AlHuthail YR. Comparison of the prevalence of psychiatric co-morbidities in hepatitis C patients and hepatitis B patients in Saudi Arabia. Saudi J Gastroenterol 2013;19:165-71. [PMID: 23828746 DOI: 10.4103/1319-3767.114514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Lotrich FE. Major depression during interferon-alpha treatment: vulnerability and prevention. Dialogues Clin Neurosci 2009;11:417-25. [PMID: 20135899 [PMID: 20135899 DOI: 10.31887/dcns.2009.11.4/felotrich] [Cited by in Crossref: 12] [Article Influence: 1.1] [Reference Citation Analysis]
3 Li Y, Zhang T, Douglas SD, Lai JP, Xiao WD, Pleasure DE, Ho WZ. Morphine enhances hepatitis C virus (HCV) replicon expression. Am J Pathol. 2003;163:1167-1175. [PMID: 12937158 DOI: 10.1016/s0002-9440(10)63476-1] [Cited by in Crossref: 52] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
4 Soliman AR, Momtaz Abd Elaziz M, El Lawindi MI. Evaluation of an isolation program of hepatitis C virus infected hemodialysis patients in some hemodialysis centers in egypt. ISRN Nephrol. 2013;2013:395467. [PMID: 24967226 DOI: 10.5402/2013/395467] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kapadia F, Latka MH, Hagan H, Golub ET, Campbell JV, Coady MH, Garfein RS, Thomas DL, Bonner S, Thiel T, Strathdee SA. Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE). J Urban Health 2007;84:99-115. [PMID: 17200799 DOI: 10.1007/s11524-006-9133-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
6 Omata M, Kanda T, Yu M, Yokosuka O, Lim S, Jafri W, Tateishi R, Hamid SS, Chuang W, Chutaputti A, Wei L, Sollano J, Sarin SK, Kao J, Mccaughan GW. APASL consensus statements and management algorithms for hepatitis C virus infection. Hepatol Int 2012;6:409-35. [DOI: 10.1007/s12072-012-9342-y] [Cited by in Crossref: 114] [Cited by in F6Publishing: 128] [Article Influence: 12.7] [Reference Citation Analysis]
7 Makuria AT, Raghuraman S, Burbelo PD, Cantilena CC, Allison RD, Gibble J, Rehermann B, Alter HJ. The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling. Transfusion 2012;52:1940-8. [PMID: 22304422 DOI: 10.1111/j.1537-2995.2011.03524.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
8 Li C, Lu L, Murphy DG, Negro F, Okamoto H. Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3e. J Gen Virol 2014;95:1677-88. [PMID: 24795446 DOI: 10.1099/vir.0.065128-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
9 McNaughton L, Puttagunta L, Martinez-Cuesta MA, Kneteman N, Mayers I, Moqbel R, Hamid Q, Radomski MW. Distribution of nitric oxide synthase in normal and cirrhotic human liver. Proc Natl Acad Sci USA. 2002;99:17161-17166. [PMID: 12482944 DOI: 10.1073/pnas.0134112100] [Cited by in Crossref: 111] [Cited by in F6Publishing: 111] [Article Influence: 5.8] [Reference Citation Analysis]
10 Cha CH, Ruo L, Fong Y, Jarnagin WR, Shia J, Blumgart LH, DeMatteo RP. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg. 2003;238:315-21; discussion 321-3. [PMID: 14501497 DOI: 10.1097/01.sla.0000086548.84705.ef] [Cited by in Crossref: 106] [Cited by in F6Publishing: 134] [Article Influence: 5.9] [Reference Citation Analysis]
11 Vassilev ZP, Strauss SM, Astone J, Des Jarlais DC. Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs. J Behav Health Serv Res 2004;31:208-16. [PMID: 15255228 DOI: 10.1007/BF02287383] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
12 Zalesak M, Francis K, Gedeon A, Gillis J, Hvidsten K, Kidder P, Li H, Martyn D, Orne L, Smith A, Kwong A. Current and future disease progression of the chronic HCV population in the United States. PLoS One. 2013;8:e63959. [PMID: 23704962 DOI: 10.1371/journal.pone.0063959] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
13 Smith JA, Aberle JH, Fleming VM, Ferenci P, Thomson EC, Karayiannis P, McLean AR, Holzmann H, Klenerman P. Dynamic coinfection with multiple viral subtypes in acute hepatitis C. J Infect Dis 2010;202:1770-9. [PMID: 21067369 DOI: 10.1086/657317] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
14 Azocar J, Diaz A. Efficacy and safety of Chlorella supplementation in adults with chronic hepatitis C virus infection. World J Gastroenterol 2013; 19(7): 1085-1090 [PMID: 23467073 DOI: 10.3748/wjg.v19.i7.1085] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
15 Ye L, Wang X, Metzger DS, Riedel E, Montaner LJ, Ho W. Upregulation of SOCS-3 and PIAS-3 impairs IL-12-mediated interferon-gamma response in CD56 T cells in HCV-infected heroin users. PLoS One 2010;5:e9602. [PMID: 20231901 DOI: 10.1371/journal.pone.0009602] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
16 Garfein RS, Stopka TJ, Pavlinac PB, Ross A, Haye BK, Riley ED, Bluthenthal RN. Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now? J Urban Health 2010;87:576-85. [PMID: 20535641 DOI: 10.1007/s11524-010-9463-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
17 Dias C, Pipa S, Mota M. Acute hepatitis C from heterosexual transmission. IDCases 2018;14:e00448. [PMID: 30191131 DOI: 10.1016/j.idcr.2018.e00448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
18 Clatts MC, Goldsamt L, Neaigus A, Welle DL. The social course of drug injection and sexual activity among YMSM and other high-risk youth: an agenda for future research. J Urban Health 2003;80:iii26-39. [PMID: 14713669 DOI: 10.1093/jurban/jtg080] [Cited by in Crossref: 9] [Cited by in F6Publishing: 23] [Article Influence: 0.5] [Reference Citation Analysis]
19 Raja M, Azzoni A, Pucci D. Characteristics of HCV positive patients in an Italian urban psychiatric unit. Clin Pract Epidemiol Ment Health 2006;2:26. [PMID: 17010216 DOI: 10.1186/1745-0179-2-26] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
20 Lotrich FE, Ferrell RE, Rabinovitz M, Pollock BG. Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha. Clin Neuropharmacol 2010;33:191-7. [PMID: 20661026 DOI: 10.1097/WNF.0b013e3181de8966] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
21 Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000;232:381-391. [PMID: 10973388 DOI: 10.1097/00000658-200009000-00010] [Cited by in Crossref: 542] [Cited by in F6Publishing: 463] [Article Influence: 25.8] [Reference Citation Analysis]
22 Davidson SS, Benjamin WH Jr. Risk of infection and tracking of work-related infectious diseases in the funeral industry. Am J Infect Control 2006;34:655-60. [PMID: 17161741 DOI: 10.1016/j.ajic.2006.05.290] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
23 Henry JA, Moloney C, Rivas C, Goldin RD. Increase in alcohol related deaths: is hepatitis C a factor? J Clin Pathol. 2002;55:704-707. [PMID: 12195003 DOI: 10.1136/jcp.55.9.704] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
24 Ahmetagić S, Muminhodzić K, Cickusić E, Stojić V, Petrović J, Tihić N. Hepatitis C infection in risk groups. Bosn J Basic Med Sci 2006;6:13-7. [PMID: 17177641 DOI: 10.17305/bjbms.2006.3111] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
25 Silasi M, Cardenas I, Kwon JY, Racicot K, Aldo P, Mor G. Viral infections during pregnancy. Am J Reprod Immunol 2015;73:199-213. [PMID: 25582523 DOI: 10.1111/aji.12355] [Cited by in Crossref: 196] [Cited by in F6Publishing: 174] [Article Influence: 32.7] [Reference Citation Analysis]
26 Cha CH, Ruo L, Fong Y, Jarnagin WR, Shia J, Blumgart LH, DeMatteo RP. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg. 2003;238:315-21; discussion 321-3. [PMID: 14501497 DOI: 10.1097/01.sla.0000086548.84705.ef.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Lansdale M, Castellino S, Marina N, Goodman P, Hudson MM, Mertens AC, Smith SM, Leisenring W, Robison LL, Oeffinger KC. Knowledge of hepatitis C virus screening in long-term pediatric cancer survivors: a report from the Childhood Cancer Survivor Study. Cancer 2010;116:974-82. [PMID: 20041485 DOI: 10.1002/cncr.24810] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
28 Dhanasekaran R, Limaye A, Cabrera R. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med. 2012;4:19-37. [PMID: 24367230 DOI: 10.2147/hmer.s16316] [Cited by in Crossref: 39] [Cited by in F6Publishing: 132] [Article Influence: 4.3] [Reference Citation Analysis]
29 Lázaro CA, Chang M, Tang W, Campbell J, Sullivan DG, Gretch DR, Corey L, Coombs RW, Fausto N. Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. Am J Pathol 2007;170:478-89. [PMID: 17255316 DOI: 10.2353/ajpath.2007.060789] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 5.3] [Reference Citation Analysis]
30 Rytsareva I, Campo DS, Zheng Y, Sims S, Thankachan SV, Tetik C, Chirag J, Chockalingam SP, Sue A, Aluru S, Khudyakov Y. Efficient detection of viral transmissions with Next-Generation Sequencing data. BMC Genomics 2017;18:372. [PMID: 28589864 DOI: 10.1186/s12864-017-3732-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
31 Stopka TJ, Garfein RS, Ross A, Truax SR. Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel. J Urban Health 2007;84:116-25. [PMID: 17151941 DOI: 10.1007/s11524-006-9122-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
32 Stopka TJ, Lutnick A, Wenger LD, Deriemer K, Geraghty EM, Kral AH. Demographic, risk, and spatial factors associated with over-the-counter syringe purchase among injection drug users. Am J Epidemiol 2012;176:14-23. [PMID: 22562660 DOI: 10.1093/aje/kwr492] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
33 Ye L, Peng JS, Wang X, Wang YJ, Luo GX, Ho WZ. Methamphetamine enhances Hepatitis C virus replication in human hepatocytes. J Viral Hepat 2008;15:261-70. [PMID: 18307590 DOI: 10.1111/j.1365-2893.2007.00940.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
34 Wang CQ, Li Y, Douglas SD, Wang X, Metzger DS, Zhang T, Ho WZ. Morphine withdrawal enhances hepatitis C virus replicon expression. Am J Pathol 2005;167:1333-40. [PMID: 16251417 DOI: 10.1016/S0002-9440(10)61220-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
35 Zhou Y, Sun L, Wang X, Zhou L, Li J, Liu M, Wang F, Peng J, Gui X, Zhao H, Reichenbach N, Zhou D, Ho WZ. Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs. J Neuroimmune Pharmacol 2015;10:102-10. [PMID: 25572448 DOI: 10.1007/s11481-014-9577-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
36 Berber E, Rogers S, Siperstein A. Predictors of survival after laparoscopic radiofrequency thermal ablation of hepatocellular cancer: a prospective study. Surg Endosc 2005;19:710-4. [PMID: 15759186 DOI: 10.1007/s00464-004-8815-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
37 Tokita H, Kaufmann GR, Matsubayashi M, Okuda I, Tanaka T, Harada H, Mukaide M, Suzuki K, Cooper DA. Hepatitis C virus core mutations reduce the sensitivity of a fluorescence enzyme immunoassay. J Clin Microbiol 2000;38:3450-2. [PMID: 10970401 DOI: 10.1128/JCM.38.9.3450-3452.2000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
38 Gerbert B, Danley DW, Herzig K, Clanon K, Ciccarone D, Gilbert P, Allerton M. Reframing "prevention with positives": incorporating counseling techniques that improve the health of HIV-positive patients. AIDS Patient Care STDS 2006;20:19-29. [PMID: 16426152 DOI: 10.1089/apc.2006.20.19] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
39 Liu Y, Ye S, Xiao X, Zhou T, Yang S, Wang G, Sun C, Zhang B, Wang G. Association of diabetes mellitus with hepatitis B and hepatitis C virus infection: evidence from an epidemiological study. Infect Drug Resist 2019;12:2875-83. [PMID: 31686868 DOI: 10.2147/IDR.S218536] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Bahtiyar G, Shin JJ, Aytaman A, Sowers JR, McFarlane SI. Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights. Curr Diab Rep. 2004;4:194-198. [PMID: 15132884 DOI: 10.1007/s11892-004-0023-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
41 Zhu LX, Liu J, Ye Y, Xie YH, Kong YY, Li GD, Wang Y. A candidate DNA vaccine elicits HCV specific humoral and cellular immune responses. World J Gastroenterol 2004; 10(17): 2488-2492 [PMID: 15300890 DOI: 10.3748/wjg.v10.i17.2488] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
42 Campo DS, Khudyakov Y. Convex hulls in hamming space enable efficient search for similarity and clustering of genomic sequences. BMC Bioinformatics 2020;21:482. [PMID: 33375937 DOI: 10.1186/s12859-020-03811-z] [Reference Citation Analysis]
43 Verstrepen BE, Boonstra A, Koopman G. Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees. World J Hepatol 2015; 7(1): 53-69 [PMID: 25624997 DOI: 10.4254/wjh.v7.i1.53] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
44 Raffaele A, Valenti M, Iovenitti M, Matani A, Bruno ML, Altobelli E, D'Alessandro A, Barnabei R, Leonardis B, Taglieri G. High prevalence of HCV infection among the general population in a rural area of central Italy. Eur J Epidemiol 2001;17:41-6. [PMID: 11523574 DOI: 10.1023/a:1010932832190] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
45 Ansaldi F, Orsi A, Sticchi L, Bruzzone B, Icardi G. Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World J Gastroenterol 2014; 20(29): 9633-9652 [PMID: 25110404 DOI: 10.3748/wjg.v20.i29.9633] [Cited by in CrossRef: 96] [Cited by in F6Publishing: 81] [Article Influence: 13.7] [Reference Citation Analysis]
46 Stopka TJ, Goulart MA, Meyers DJ, Hutcheson M, Barton K, Onofrey S, Church D, Donahue A, Chui KKH. Identifying and characterizing hepatitis C virus hotspots in Massachusetts: a spatial epidemiological approach. BMC Infect Dis 2017;17:294. [PMID: 28427355 DOI: 10.1186/s12879-017-2400-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
47 Edlin BR, Seal KH, Lorvick J, Kral AH, Ciccarone DH, Moore LD, Lo B. Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? N Engl J Med 2001;345:211-5. [PMID: 11463019 DOI: 10.1056/NEJM200107193450311] [Cited by in Crossref: 149] [Cited by in F6Publishing: 53] [Article Influence: 7.5] [Reference Citation Analysis]
48 Guo X, Zhong JY, Li JW. Hepatitis C Virus Infection and Vaccine Development. J Clin Exp Hepatol 2018;8:195-204. [PMID: 29892184 DOI: 10.1016/j.jceh.2018.02.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
49 Ismail A, Fouad O, Abdelnasser A, Chowdhury A, Selim A. Stem cell therapy improves the outcome of liver resection in cirrhotics. J Gastrointest Cancer. 2010;41:17-23. [PMID: 20012230 DOI: 10.1007/s12029-009-9092-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
50 Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013;10:553-562. [PMID: 23817321 DOI: 10.1038/nrgastro.2013.107] [Cited by in Crossref: 625] [Cited by in F6Publishing: 582] [Article Influence: 78.1] [Reference Citation Analysis]
51 Campo DS, Xia GL, Dimitrova Z, Lin Y, Forbi JC, Ganova-Raeva L, Punkova L, Ramachandran S, Thai H, Skums P, Sims S, Rytsareva I, Vaughan G, Roh HJ, Purdy MA, Sue A, Khudyakov Y. Accurate Genetic Detection of Hepatitis C Virus Transmissions in Outbreak Settings. J Infect Dis 2016;213:957-65. [PMID: 26582955 DOI: 10.1093/infdis/jiv542] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
52 Pybus OG, Barnes E, Taggart R, Lemey P, Markov PV, Rasachak B, Syhavong B, Phetsouvanah R, Sheridan I, Humphreys IS. Genetic history of hepatitis C virus in East Asia. J Virol. 2009;83:1071-1082. [PMID: 18971279 DOI: 10.1128/jvi.01501-08] [Cited by in Crossref: 153] [Cited by in F6Publishing: 92] [Article Influence: 11.8] [Reference Citation Analysis]